The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer
Open Access
- 15 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 42 (7), 569-577
- https://doi.org/10.1093/jjco/hys072
Abstract
Men are at a higher risk of developing bladder cancer than women. Since bladder cancer cell lines and tissues were found to express the androgen receptor, efforts have been made to inspect whether androgen-mediated androgen receptor signals are implicated in bladder carcinogenesis as well as cancer progression. Mounting evidence supports the view that bladder cancer is a member of the endocrine-related tumors and may clearly explain the gender-specific difference in the incidence. However, the underlying mechanisms of how androgen receptor signals regulate bladder cancer growth are still far from fully characterized. Moreover, it remains controversial whether the androgen receptor pathway always plays a dominant role in bladder cancer progression. In this review, we summarize the available data on the involvement of androgen receptor signaling in bladder cancer. In particular, current evidence demonstrating the stimulatory effects of androgens on tumor progression or, more convincingly, tumorigenesis via the androgen receptor pathway may offer great potential for androgen deprivation as a therapeutic or chemopreventive option in patients with bladder cancer.Keywords
This publication has 60 references indexed in Scilit:
- Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancerMolecular Carcinogenesis, 2011
- Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cellsThe Prostate, 2010
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladderEndocrine-Related Cancer, 2009
- Targeting the stromal androgen receptor in primary prostate tumors at earlier stagesProceedings of the National Academy of Sciences of the United States of America, 2008
- Lower urinary-tract symptoms and testosterone in elderly menWorld Journal of Urology, 2008
- Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1BMC Urology, 2008
- Androgen and estrogen receptor–mediated mechanisms of testosterone action in male rat pelvic autonomic gangliaNeuroscience, 2007
- HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?European Journal of Cancer, 2004